Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Abstract The RAS/mitogen-activated protein kinase (MAPK) signaling cascade is commonly dysregulated in human malignancies by processes driven by RAS or RAF oncogenes. Among the members of the RAF kinase family, CRAF plays an important role in the RAS-MAPK signaling pathway, as well as in the progres...
Main Authors: | Penglei Wang, Kyle Laster, Xuechao Jia, Zigang Dong, Kangdong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-023-01903-x |
Similar Items
-
Sex disparities in non-small cell lung cancer: mechanistic insights from a cRaf transgenic disease modelResearch in context
by: Shen Zhong, et al.
Published: (2023-09-01) -
Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation
by: Tarah Elizabeth Trebino, et al.
Published: (2023-12-01) -
CRAF dimerization with ARAF regulates KRAS-driven tumor growth
by: Avinashnarayan Venkatanarayan, et al.
Published: (2022-02-01) -
Crystal Structure Reveals the Full Ras–Raf Interface and Advances Mechanistic Understanding of Raf Activation
by: Trinity Cookis, et al.
Published: (2021-07-01) -
Recent advances in targeting protein kinases and pseudokinases in cancer biology
by: Kristina Riegel, et al.
Published: (2022-07-01)